These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23311938)

  • 1. Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
    Watanabe T; Ohtani T; Aihara M; Ishiuchi S
    J Neurosurg; 2013 Apr; 118(4):838-45. PubMed ID: 23311938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models.
    Netland IA; Førde HE; Sleire L; Leiss L; Rahman MA; Skeie BS; Gjerde CH; Enger PØ; Goplen D
    BMC Cancer; 2016 Aug; 16():657. PubMed ID: 27542970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans.
    Faried A; Arifin MZ; Ishiuchi S; Kuwano H; Yazawa S
    J Neurosurg; 2014 Jun; 120(6):1298-308. PubMed ID: 24678780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.
    Ranjan A; Srivastava SK
    Oncotarget; 2017 May; 8(20):32960-32976. PubMed ID: 28380428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.
    Ishiuchi S; Tsuzuki K; Yoshida Y; Yamada N; Hagimura N; Okado H; Miwa A; Kurihara H; Nakazato Y; Tamura M; Sasaki T; Ozawa S
    Nat Med; 2002 Sep; 8(9):971-8. PubMed ID: 12172541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
    Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
    J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.
    Haberler C; Gelpi E; Marosi C; Rössler K; Birner P; Budka H; Hainfellner JA
    J Neurooncol; 2006 Jan; 76(2):105-9. PubMed ID: 16205964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats.
    Netland IA; Førde HE; Sleire L; Leiss L; Rahman MA; Skeie BS; Miletic H; Enger PØ; Goplen D
    J Neurooncol; 2016 Aug; 129(1):57-66. PubMed ID: 27283525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
    Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
    Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.
    Zhao HF; Wang J; Jiang HR; Chen ZP; To SS
    J Exp Clin Cancer Res; 2016 May; 35():78. PubMed ID: 27176481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.
    Lee EJ; Sung JY; Koo KH; Park JB; Kim DH; Shim J; Lee CH; Park J; Kim YN
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
    Roberts WG; Whalen PM; Soderstrom E; Moraski G; Lyssikatos JP; Wang HF; Cooper B; Baker DA; Savage D; Dalvie D; Atherton JA; Ralston S; Szewc R; Kath JC; Lin J; Soderstrom C; Tkalcevic G; Cohen BD; Pollack V; Barth W; Hungerford W; Ung E
    Cancer Res; 2005 Feb; 65(3):957-66. PubMed ID: 15705896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.
    Vaglini F; Pardini C; Di Desidero T; Orlandi P; Pasqualetti F; Ottani A; Pacini S; Giuliani D; Guarini S; Bocci G
    Mol Neurobiol; 2018 Jun; 55(6):4984-4997. PubMed ID: 28791594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway.
    Zhu YG; Lv YX; Guo CY; Xiao ZM; Jiang QG; Kuang H; Zhang WH; Hu P
    Life Sci; 2021 Apr; 270():119112. PubMed ID: 33508300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression.
    Wang Z; Liu F; Liao W; Yu L; Hu Z; Li M; Xia H
    Arch Biochem Biophys; 2020 Aug; 689():108412. PubMed ID: 32445778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
    Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
    Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
    Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.